Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.
about
Technologies for controlled, local delivery of siRNANanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiationBioactive factor delivery strategies from engineered polymer hydrogels for therapeutic medicine.Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells.Degradable polyelectrolyte multilayers that promote the release of siRNAFunctionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells.Controlling fibrous capsule formation through long-term down-regulation of collagen type I (COL1A1) expression by nanofiber-mediated siRNA gene silencing.Controlled Angiogenesis in Peptide Nanofiber Composite HydrogelsExtracellular matrix-based biomaterial scaffolds and the host response.Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.Implementing tissue engineering and regenerative medicine solutions in medical implants.PEG-Immobilized Keratin for Protein Drug Sequestration and pH-Mediated DeliveryPhotocrosslinkable, biodegradable hydrogels with controlled cell adhesivity for prolonged siRNA delivery to hMSCs to enhance their osteogenic differentiation.Invasive Intraneural Interfaces: Foreign Body Reaction Issues.Dependence of macrophage superoxide release on the pulse amplitude of an applied pressure regime: a potential factor at the soft tissue-implant interface.
P2860
Q28087657-03C0684C-4C9F-427F-9448-03E84904A007Q33935474-F46E93D8-BC0D-42E2-8456-6E8391590CF8Q34147775-DFD6D3C0-66B6-49BB-BE10-29C157F30B1DQ34204037-77DD8D76-DC01-48F7-900C-2AD892268DB5Q34533701-01517456-83E4-476A-9BF7-2273D33EAA27Q35046391-416DB69B-6934-4948-A1A2-4BB496096E94Q36428234-48D8C13E-03B4-40C2-9082-A3DAEEC9F417Q36471117-E6868E51-7174-4D23-AA34-0DABA2C3538BQ36623213-8DBE9606-E295-47DE-B6BA-947D01233DFCQ36669532-51FDFFB3-34F6-4197-AF9F-0A0246D81E26Q38010629-6B289588-B8C6-413B-970B-FDAABDAC9B24Q38172911-2F56044A-02AE-4957-9029-78EE951DF21EQ38287296-8292FB06-7705-4D34-944D-3CA1607B7F96Q38707859-F1B385ED-B2F5-4548-B03D-4B17836FB628Q41439977-EFB1EDE3-88F7-41D1-AE0B-057573218013Q45349117-A991A589-B858-4175-8046-16086E7F0EEE
P2860
Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Device-based local delivery of ...... inhibit fibrous encapsulation.
@ast
Device-based local delivery of ...... inhibit fibrous encapsulation.
@en
Device-based local delivery of siRNA against mammalian target of rapamycin
@nl
type
label
Device-based local delivery of ...... inhibit fibrous encapsulation.
@ast
Device-based local delivery of ...... inhibit fibrous encapsulation.
@en
Device-based local delivery of siRNA against mammalian target of rapamycin
@nl
prefLabel
Device-based local delivery of ...... inhibit fibrous encapsulation.
@ast
Device-based local delivery of ...... inhibit fibrous encapsulation.
@en
Device-based local delivery of siRNA against mammalian target of rapamycin
@nl
P2093
P2860
P1476
Device-based local delivery of ...... inhibit fibrous encapsulation.
@en
P2093
David W Grainger
Hironobu Takahashi
Yuwei Wang
P2860
P304
P356
10.1016/J.JCONREL.2010.08.019
P407
P577
2010-08-19T00:00:00Z